Novo Nordisk invests $1.2 billion in new rare disease drugs plant in Denmark
By Anna Ringstrom and Maggie Fick STOCKHOLM/LONDON (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the production of rare disease drugs, it said on Monday. The site will manufacture various types of rare disease drugs, including those for the treatment of haemophilia, Novo …
Novo Nordisk invests $1.2 billion in new rare disease drugs plant in Denmark Read More »